Delivery Order SPE2DB22D1017-SPE2DB25FYPRX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.29 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Sunosi 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on July 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,128.85 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,721.90 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count packages) valued at $1,344.45. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contract is scheduled for ultimate completion on September 19, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 17, 2025, for the supply of Sunosi 75 mg tablets (30-count units) with a ceiling value of $4,264.03. This non-set-aside contract represents a firm fixed price delivery order and is part of AmerisourceBergen's broader engagement with DLA's medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 18,...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract value of $2,570.36 and a firm fixed price structure. This delivery order, valued at the ceiling amount specified, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work is to be performed at the company's corporate office in Conshohocken, Pennsylvania, and the...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a $1,881.03 delivery order to AmerisourceBergen Drug Corp for Sunosi 75 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPRXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,792.60 to AmerisourceBergen Drug Corp for the supply of Sunosi (solriamfetol) 75 mg tablets in a 30-count package. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, and the place of performance is located at the company's corporate office in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Sunosi is a wakefulness-promoting agent primarily used to treat excessive daytime sleepiness associated with narcolepsy, making this delivery order consistent with AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical procurement needs for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/2/25 |